Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
MammaPrint predicts chemotherapy benefit in HR+HER2- early breast cancer: FLEX Registry real-world data.
Journal: JNCI cancer spectrum
Published: April 22, 2025
Does the false-negative rate for 1 or 2 negative sentinel nodes after neo-adjuvant chemotherapy translate into a high local recurrence rate?
Journal: The breast journal
Published: September 11, 2020
Showing 1-2 of 2
Last Updated: 09/26/2026